153 related articles for article (PubMed ID: 8226837)
1. A conjugate between human urokinase and saporin, a type-1 ribosome-inactivating protein, is selectively cytotoxic to urokinase receptor-expressing cells.
Cavallaro U; del Vecchio A; Lappi DA; Soria MR
J Biol Chem; 1993 Nov; 268(31):23186-90. PubMed ID: 8226837
[TBL] [Abstract][Full Text] [Related]
2. The amino-terminal fragment of human urokinase directs a recombinant chimeric toxin to target cells: internalization is toxin mediated.
Fabbrini MS; Carpani D; Bello-Rivero I; Soria MR
FASEB J; 1997 Nov; 11(13):1169-76. PubMed ID: 9367352
[TBL] [Abstract][Full Text] [Related]
3. Targeting plant toxins to the urokinase and alpha 2-macroglobulin receptors.
Cavallaro U; Soria MR
Semin Cancer Biol; 1995 Oct; 6(5):269-78. PubMed ID: 8562904
[TBL] [Abstract][Full Text] [Related]
4. Endocytosis of a chimera between human pro-urokinase and the plant toxin saporin: an unusual internalization mechanism.
Ippoliti R; Lendaro E; Benedetti PA; Torrisi MR; Belleudi F; Carpani D; Soria MR; Fabbrini MS
FASEB J; 2000 Jul; 14(10):1335-44. PubMed ID: 10877826
[TBL] [Abstract][Full Text] [Related]
5. PMA-induced down-regulation of the receptor for alpha 2-macroglobulin in human U937 cells.
Conese M; Cavallaro U; Sidenius N; Olson D; Soria MR; Blasi F
FEBS Lett; 1995 Jan; 358(1):73-8. PubMed ID: 7821434
[TBL] [Abstract][Full Text] [Related]
6. alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor.
Conese M; Nykjaer A; Petersen CM; Cremona O; Pardi R; Andreasen PA; Gliemann J; Christensen EI; Blasi F
J Cell Biol; 1995 Dec; 131(6 Pt 1):1609-22. PubMed ID: 8522616
[TBL] [Abstract][Full Text] [Related]
7. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.
Olson D; Pöllänen J; Høyer-Hansen G; Rønne E; Sakaguchi K; Wun TC; Appella E; Danø K; Blasi F
J Biol Chem; 1992 May; 267(13):9129-33. PubMed ID: 1315748
[TBL] [Abstract][Full Text] [Related]
8. Protease nexin-1-urokinase complexes are internalized and degraded through a mechanism that requires both urokinase receptor and alpha 2-macroglobulin receptor.
Conese M; Olson D; Blasi F
J Biol Chem; 1994 Jul; 269(27):17886-92. PubMed ID: 8027043
[TBL] [Abstract][Full Text] [Related]
9. Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation.
Conese M; Blasi F
Biol Chem Hoppe Seyler; 1995 Mar; 376(3):143-55. PubMed ID: 7612191
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of ribosome-inactivating protein saporin is not mediated through alpha2-macroglobulin receptor.
Bagga S; Hosur MV; Batra JK
FEBS Lett; 2003 Apr; 541(1-3):16-20. PubMed ID: 12706812
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase-type-plasminogen-activator receptor in THP-1 cells. Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the cell surface.
Ragno P; Montuori N; Rossi G
Eur J Biochem; 1995 Oct; 233(2):514-9. PubMed ID: 7588796
[TBL] [Abstract][Full Text] [Related]
12. The anti-tumoral potential of the saporin-based uPAR-targeting chimera ATF-SAP.
Zuppone S; Assalini C; Minici C; Bertagnoli S; Branduardi P; Degano M; Fabbrini MS; Montorsi F; Salonia A; Vago R
Sci Rep; 2020 Feb; 10(1):2521. PubMed ID: 32054892
[TBL] [Abstract][Full Text] [Related]
13. Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor.
Li H; Kuo A; Kochan J; Strickland D; Kariko K; Barnathan ES; Cines DB
J Biol Chem; 1994 Mar; 269(11):8153-8. PubMed ID: 7510679
[TBL] [Abstract][Full Text] [Related]
14. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
Czekay RP; Kuemmel TA; Orlando RA; Farquhar MG
Mol Biol Cell; 2001 May; 12(5):1467-79. PubMed ID: 11359936
[TBL] [Abstract][Full Text] [Related]
15. Basic FGF-SAP mitotoxin in the hippocampus. Specific lethal effect on cells expressing the basic FGF receptor.
Gonzalez AM; Lappi DA; Buscaglia ML; Carman LS; Gage FH; Baird A
Ann N Y Acad Sci; 1991; 638():442-4. PubMed ID: 1664696
[No Abstract] [Full Text] [Related]
16. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
17. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
Ohba K; Miyata Y; Kanda S; Koga S; Hayashi T; Kanetake H
J Urol; 2005 Aug; 174(2):461-5. PubMed ID: 16006865
[TBL] [Abstract][Full Text] [Related]
18. Basic fibroblast growth factor-saporin mitotoxin. In vitro studies of its cell-killing activity and of substances that alter that activity.
Martineau D; Lappi DA; Amburn E; Baird A
Ann N Y Acad Sci; 1991; 638():438-41. PubMed ID: 1785818
[No Abstract] [Full Text] [Related]
19. Characterization of a saporin isoform with lower ribosome-inhibiting activity.
Fabbrini MS; Rappocciolo E; Carpani D; Solinas M; Valsasina B; Breme U; Cavallaro U; Nykjaer A; Rovida E; Legname G; Soria MR
Biochem J; 1997 Mar; 322 ( Pt 3)(Pt 3):719-27. PubMed ID: 9148741
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
